Get yer annual OSHA training

If you give immunizations, you’ll probably want to get your annual OSHA update. (Can you say “bloodborne pathogens training”?)

Take it online from the comfort of your living room, with GPhA’s webinar, “The Dreaded OSHA Update.”

The deets: 60-minutes. September 7 at 7:30 PM. A mere $20.

Click here to sign up today!

Was it you?

One in 10 Georgians was affected by a healthcare data breach in the past year.

Immunize Georgia is coming

The headline says it all: The annual conference is being held Friday, September 15 at the Columbus Convention and Trade Center. Register to “learn the latest recommendations and best practices in immunization services.”

Check out the agenda here, or click here for all the info.

FDA approves country’s first gene therapy

The U.S. has just approved the first genetic treatment — specifically for childhood leukemia. Novartis’s use of CAR-T cells will cost $475,000, but it said there would be no charge for patients who didn’t show a response within a month.

CAR-T treatment uses gene therapy techniques not to fix disease-causing genes but to turbocharge T cells, immune system soldiers that cancer too often can evade. Researchers filter those cells from a patient’s blood, reprogram them to harbor a “chimeric antigen receptor” or CAR that zeroes in on cancer, and grow hundreds of millions of copies. Returned to the patient, the revved-up cells can continue multiplying to fight disease for months or years.

Opioid-maker lawsuit watch

Bensalem, Pa., sues opioid makers.

Missouri widens its lawsuit with “investigative demands.”

Beauty watch

Beyond the pale

Yet another reason — besides, you know, skin cancer — not to use a tanning bed.

Stories you wouldn’t think needed to be told

Instagram isn’t the place to find a plastic surgeo